These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38627107)

  • 1. Estimation of the incidence of urachal cancer: A systematic review and meta-analysis of registry-based studies.
    Olah C; Kubik A; Mátrai P; Engh MA; Barna V; Hegyi P; Reis H; Nyirády P; Szarvas T
    Urol Oncol; 2024 Jul; 42(7):221.e1-221.e7. PubMed ID: 38627107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
    Szarvas T; Módos O; Niedworok C; Reis H; Szendröi A; Szász MA; Nyirády P
    Urol Oncol; 2016 Sep; 34(9):388-98. PubMed ID: 27267737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features of malignant urachal tumor: A hospital-based cancer registry data in Japan.
    Nagumo Y; Kojima T; Shiga M; Kojo K; Tanaka K; Kandori S; Kimura T; Kawahara T; Kawai K; Okuyama A; Higashi T; Nishiyama H
    Int J Urol; 2020 Feb; 27(2):157-162. PubMed ID: 31793080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
    Módos O; Reis H; Niedworok C; Rübben H; Szendröi A; Szász MA; Tímár J; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollósi P; Nyirády P; Szarvas T
    Oncotarget; 2016 Jun; 7(26):39293-39301. PubMed ID: 27283768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urachal Cancer in Germany and the USA: An RKI/SEER Population-Based Comparison Study.
    Hager T; Kraywinkel K; Szarvas T; Hadaschik B; Schmid KW; Reis H
    Urol Int; 2020; 104(9-10):803-809. PubMed ID: 32784300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
    Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
    Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
    Reis H; Krafft U; Niedworok C; Módos O; Herold T; Behrendt M; Al-Ahmadie H; Hadaschik B; Nyirady P; Szarvas T
    Dis Markers; 2018; 2018():7308168. PubMed ID: 29721106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of MRI in evaluating urachal carcinoma: A single center retrospective study.
    Das JP; Woo S; Ghafoor S; Andrieu PIC; Ulaner GA; Donahue TF; Goh AC; Vargas HA
    Urol Oncol; 2022 Jul; 40(7):345.e9-345.e17. PubMed ID: 35351368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical epidemiology of urachal carcinoma: results of a large, population based study.
    Bruins HM; Visser O; Ploeg M; Hulsbergen-van de Kaa CA; Kiemeney LA; Witjes JA
    J Urol; 2012 Oct; 188(4):1102-7. PubMed ID: 22901574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
    Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
    Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Shao G; Xu C; Liu J; Li X; Li L; Li X; Zhang X; Fan Y; Zhou L
    Urol Int; 2022; 106(2):199-208. PubMed ID: 34515250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
    Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
    Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Value of FDG-PET/CT for Urachal Cancer.
    Stokkel LE; Stokkel MPM; Donswijk ML; Lahaye MJ; Bekers EM; van Rhijn BWG; Mertens LS
    Clin Genitourin Cancer; 2021 Oct; 19(5):373-380. PubMed ID: 33858788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group.
    Guerin M; Miran C; Colomba E; Cabart M; Herrmann T; Pericart S; Maillet D; Neuzillet Y; Deleuze A; Coquan E; Laramas M; Thibault C; Abbar B; Mesnard B; Borchiellini D; Dumont C; Boughalem E; Deville JL; Cancel M; Saldana C; Khalil A; Baciarello G; Flechon A; Walz J; Gravis G
    Front Oncol; 2023; 13():1110003. PubMed ID: 36741023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on "The clinical epidemiology of urachal carcinoma: results of a large, population based study." Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LA, Witjes JA, Department of Urology, Radboud University Medical Centre, Utrecht, The Netherlands: J Urol 2012;188(4):1102-7 [Epub 2012 Aug 15].
    Kamat AM
    Urol Oncol; 2013 Jul; 31(5):720. PubMed ID: 23796205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative accuracy of diagnostic evaluation of urachal carcinoma.
    Ke C; Hu Z; Yang C
    Cancer Med; 2023 Apr; 12(8):9106-9115. PubMed ID: 36734315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.